{"nct_id":"NCT01646021","title":"Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy","status":"COMPLETED","status_verified_date":"2017-12","start_date":"2012-12-10","start_date_type":"ACTUAL","primary_completion_date":"2015-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}